Brings industry veterans in AI and healthcare to support fast growth
AUSTIN, Texas–(BUSINESS WIRE)–Autonomize AI, a pioneer in AI-driven healthcare solutions, announced two key appointments to its leadership team: Jennifer Kloke, PhD, as Vice President of Artificial Intelligence (AI), and Jeffrey Eyestone as Vice President of Business Development.
“We are thrilled to welcome Jennifer and Jeffrey to our team. Their vast experience and innovative vision will be crucial as we continue to expand the possibilities of AI in healthcare.”Post this
Dr. Jennifer Kloke steps into her role as an accomplished leader in AI product innovation. Her tenure at LinkedIn saw the creation of groundbreaking features like the LLM-based ‘Enhance Your Profile’ and AI-generated InMail, significantly boosting user engagement and revenue. Previously, as VP of Product and CTO at Ayasdi, she was instrumental in advancing their healthcare AI platform, notably through the development of Ayasdi CARE, which revolutionized care pathways in hospitals. Jennifer’s expertise in integrating AI with user-centric product design is key in driving AI adoption in healthcare for Autonomize.
Jeffrey Eyestone brings over 25 years of experience in Healthcare AI and Information Technology. His career has been marked by significant contributions to the development of AI solutions for major healthcare entities such as United Healthcare and CVS Health. Jeffrey’s expertise encompasses a broad spectrum of AI applications, from care management to sales acceleration, benefiting top-tier payers, providers, and life sciences organizations. His prior roles at prestigious firms like J.P. Morgan and Wells Fargo, coupled with entrepreneurial success, have equipped him well for his new role. Jeffrey holds an MBA from the London Business School and a bachelor’s degree from Lafayette College.
Ganesh Padmanabhan, CEO of Autonomize AI, expressed his enthusiasm about the new additions: “We are thrilled to welcome Jennifer and Jeffrey to our team. Their vast experience and innovative vision will be crucial as we continue to expand the possibilities of AI in healthcare.”
These appointments come at a pivotal time for Autonomize AI, as it gears up for significant growth and innovation, reinforcing its position as a leader in healthcare AI.
About Autonomize AI
Autonomize’s AI copilots organize, contextualize and summarize unstructured data to reduce the administrative burden for healthcare knowledge workers to make data-driven decisions and improve patient outcomes. Autonomize AI is a founding member of CancerX, the US President’s Cancer Moonshot initiative. Our customers include Top 20 pharma, F100 Payors and life sciences companies.
Contacts
Discover more from Impact Newswire
Subscribe to get the latest posts sent to your email.
